Excited to share that my PhD dissertation work examining primary treatment modification among older adults with cancer has been selected for oral presentation at the upcoming ASCO meeting #ASCO24 . Grateful for this incredible opportunity! #gerionc Cancer and Aging Research Group (CARG) #GeriOnc URochester SMD

Honored our JAMA Network Open article examining chemo tx modification in older adults with advanced cancer is featured in Medscape.
More robust tx data are needed in this population Supriya Mohile Jenny Lund Cancer and Aging Research Group (CARG) #GeriOnc #gerionc
medscape.com/viewarticle/ca…

Glad to have the opportunity to discuss our research JAMA Network Open examining chemo dosing decisions among older adults with advanced cancer at Cancerworld.
We need more robust evidence-based treatment data for this population. Cancer and Aging Research Group (CARG) #GeriOnc Young SIOG
cancerworld.net/older-adults-a…

A new @jamanetworkopen study shows that lowering the dose and adjusting the schedule of how chemotherapy is given to older adults with advanced cancer can make life better without compromising treatment goals.

Thanks Mostafa R Mohamed for leading the work!

jamanetwork.com/journals/jaman…

🔉Join us at the upcoming bi-weekly Cancer and Aging Research Group (CARG) #GeriOnc meeting!
11/14 at 11am PT/2pm ET
Co-leads: Drs. William Dale, MD, PhD, FASCO and Manvi Sharma
*Agenda*
-Implementation of the #PracticalGA
-Primary Treatment Modification Strategies among Older Adults with Advanced Cancer by Mostafa R Mohamed #YoungSIOG

It has been a privilege to be a Young SIOG investigator award finalist- thank you for all mentors and colleagues for their help and support! Supriya Mohile Jenny Lund Wilmot Cancer Institute SIOG

After I completed my PhD journey, I am excited to start a faculty position as a Res. Assistant Professor URMC Department of Medicine at division of hematology & oncology. Looking forward to doing innovative research with the amazing #gerionc group and other brilliant researchers Wilmot Cancer Institute

Older adults with advanced cancer report pain not captured by clinician-graded Common Terminology Criteria for Adverse Events (CTCAE) geriatriconcology.net/article/S1879-… Mostafa R Mohamed Allison Magnuson, DO, MS Supriya Mohile William Dale, MD, PhD, FASCO Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Pain

I am incredibly proud of the amazing Young SIOG publishing a thoughtful commentary on second-line FOLFOX in aBTC in the Annals of Oncology, the official journal of the ESMO - Eur. Oncology.
#gerionc SIOG #biliarytract
#clinicaltrials

annalsofoncology.org/article/S0923-…

🎉Congratulations Supriya Mohile, MD (Supriya Mohile) for earning a place with the American Society for Clinical Investigation!

She has made her mark in the field of Geriatric Oncology through her groundbreaking #URochesterResearch
ASCI Wilmot Cancer Institute
urmc.rochester.edu/news/story/sup…

We are now focused on creating a clinical research infrastructure to support studies focused on older adults with cancer and include a geriatric assessment. These 5 new studies will help us build the CARG National Consortia of Clinical Trials!
#gerionc #geriheme #CARG2023

New evidence of risks of polypharmacy, PIMs, and (especially new) drug-drug interactions in older adults with cancer receiving chemotherapy. +signal that geri assessment-guided care can mitigate these risks. Mostafa R Mohamed Supriya Mohile Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC Cancer and Aging Research Group (CARG) #GeriOnc @Deprescribing

New & #OpenAccess |  In a cohort of older adults with advanced cancer, polypharmacy and potential drug-drug interactions are associated with increased risk of adverse treatment outcomes. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Mostafa R Mohamed Cancer and Aging Research Group (CARG) #GeriOnc Wilmot Cancer Institute Vivek Subbiah, MD #gerionc

Happening now the amazing Dr. Mostafa R Mohamed talking about his work in chemotherapy dosing in older adults with cancer! Wilmot Cancer Institute

Mostafa R Mohamed (Dr. Mostafa Mohamed) presents his award winning PhD work at Wilmot Cancer Institute evaluating tolerability outcomes of older patients with cancer using GAP70+ data. Thankful for Wilmot Cancer Institute for inviting students to present. #gerionc

Summary of a truly ‘must see’ presentation by Dr Bishal Gyawali for ALL who treat #cancer patients. Everywhere.
(Will post and look for link to videos ⁦ecancer⁩ )